<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>0</Volume><Issue>0</Issue><PubDate PubStatus="epublish"><Year>2016</Year><Month>08</Month><Day>24</Day></PubDate></Journal><title locale="en_US">Administration of Lactobacillus casei and Bifidobacterium bifidum Ameliorated Hyperglycemia, Dyslipidemia, and Oxidative Stress in Diabetic Rats</title><FirstPage>1727</FirstPage><LastPage>1727</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Zoology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh</affiliation></Author><Author><affiliation locale="en_US">Department of Biomedical Science, Bundelkhand University, Jhansi, Uttar Pradesh</affiliation></Author><Author><affiliation locale="en_US">Department of Biomedical Science, Bundelkhand University, Jhansi, Uttar Pradesh</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>24</Day></PubDate></History><abstract locale="en_US">&lt;strong&gt;Background:&lt;/strong&gt; The present work was planned to evaluate the antihyperglycemic, lipid‑lowering, and&lt;br /&gt;antioxidant effect of Lactobacillus casei and Bifidobacterium bifidum in streptozotocin (STZ)‑induced&lt;br /&gt;diabetic rats.&lt;br /&gt;&lt;strong&gt;Methods:&lt;/strong&gt; Single daily dose of 1 &amp;times; 107 cfu/ml of L. casei and B. bifidum alone and in combination of&lt;br /&gt;both was given to Wistar rats orally by gavaging for 28 days. Glucose tolerance test, fasting blood&lt;br /&gt;glucose (FBG), lipid profile, and glycosylated hemoglobin (HbA1c) were measured from blood.&lt;br /&gt;Glycogen from thigh muscles and liver and oxidative stress parameters from pancreas were analyzed.&lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; Administration of L. casei and B. bifidum alone and in combination of both to diabetic rats&lt;br /&gt;decreased serum FBG (60.47%, 55.89%, and 56.49%, respectively), HbA1c (28.11%, 28.61%,&lt;br /&gt;and 28.28%), total cholesterol (171.69%, 136.47%, and 173.58%), triglycerides (9.935%, 8.58%,&lt;br /&gt;and 7.91%), low‑density lipoproteins (53.27%, 53.35%, and 52.91%) and very low‑density&lt;br /&gt;lipoproteins (10%, 8.58%, and 11.15%, respectively) and increased high‑density lipoproteins (13.73%,&lt;br /&gt;15.47%, and 15.47%), and insulin (19.50%, 25.80%, and 29.47%, respectively). The treatment also&lt;br /&gt;resulted in increase in muscle (171.69%, 136.47%, and 173.58%) and liver (25.82%, 6.63%, and&lt;br /&gt;4.02%) glycogen level. The antioxidant indexes in pancreas of diabetic rats returned to normal&lt;br /&gt;level with reduction in lipid peroxidation (30.89%, 46.46%, and 65.36%) and elevation in reduced&lt;br /&gt;glutathione (104.5%, 161.34%, and 179.04%), superoxide dismutase (38.65%, 44.32%, and 53.35%),&lt;br /&gt;catalase (13.08%, 27%, and 31.52%), glutathione peroxidase (55.56%, 72.23%, and 97.23%),&lt;br /&gt;glutathione reductase (49.27%, 88.40%, and 110.86%), and glutathione‑S‑transferase (140%,&lt;br /&gt;220%, and 246.6%, respectively) on treatment with L. casei, B. bifidum, and combination treatment.&lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; Administration of L. casei and B. bifidum alone and in combination of both&lt;br /&gt;ameliorated hyperglycemia, dyslipidemia, and oxidative stress in STZ‑induced diabetic Wistar rats.&lt;br /&gt;&lt;strong&gt;Keywords:&lt;/strong&gt; Antihyperglycemic, antioxidant, Bifidobacterium bifidum, dyslipidemia, Lactobacillus&lt;br /&gt;casei</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1727</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1727/2017</pdf_url></Article></Articles>
